Haleon launches with purpose to deliver better everyday health with humanity
- Maker of Panadol, Centrum, Sensodyne and Voltaren becomes one of the world’s leading independent consumer health companies
- Demerger from GSK plc (GSK) now complete
Haleon (LSE/NYSE: HLN) launches as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver better everyday health with humanity.
Trading commenced on Monday on the London Stock Exchange (LSE), with Brian McNamara, CEO of Haleon, leading the opening ceremony to signal the start of trading. Trading on the New York Stock Exchange (NYSE) is set to follow1, and a similar market-opening event will take place on [Wednesday 20 July 2022].
Haleon has a world-class portfolio of brands including Panadol, Sensodyne and Centrum, and will continue to develop category leading brands that address real consumer health needs, while focusing on future innovation across its entire portfolio.
With an increased consumer focus on health and wellness, an ageing global population, an emerging middle class in high-growth economies, growing self-care in the face of increased pressure on public healthcare systems and sizeable unmet consumer needs, Haleon has launched at a time when the consumer healthcare market is set for expansion (expected to be at a rate of 3-4% per annum over the medium-term). Haleon expects to deliver medium-term annual organic revenue growth of 4-6%.
Despite huge improvements in medicine, data and technology, everyday health remains elusive for too many people. Haleon aims to change this through a two-pronged approach. First, by working to remove barriers to better everyday health, and second, by aiming to empower 50 million people a year by 2025 to be more included in opportunities for better everyday health.
The company’s competitive advantage lies in its ability to blend deep human understanding and trusted science in the products it creates. Haleon is further distinguished by leading consumer healthcare-focused scientific capabilities, a well-developed organisational understanding of human health behaviours, strong capabilities in brand building, innovation and digital commerce and a powerful route-to-market.
The brands within the Haleon portfolio have been providing treatment and improving the quality of life for millions of consumers across the globe for decades. They have also been trusted, recognised, and recommended by healthcare professionals across multiple markets.
Brian McNamara, Chief Executive Officer, Haleon, said:
“This is a significant milestone for Haleon. Guided by our clear purpose and with a world class portfolio of brands that people know and trust, we stand ready to help address consumer needs and make better everyday health more achievable, inclusive and sustainable.
“Consumer health has never been more important than it is today, and I am delighted that Haleon, as an independent company, is ready to pursue our ambitions.
“Today follows a huge amount of effort, planning and collaboration by our dedicated colleagues all around the world.”
Dave Barrett, Country Manager, Ireland, Haleon, said:
“I couldn’t be more delighted to be celebrating this milestone of Haleon becoming an independent company. Our purpose is to ‘deliver better everyday health with humanity’ and as a global leader now 100% focused on improving consumer health, we are dedicated to making better everyday health more achievable, inclusive and sustainable.
In Ireland, Haleon employs over 930 people, including 900 at our manufacturing facility in Dungarvan, Waterford. This site is one of the largest manufacturing sites in Haleon’s Consumer Health network, producing 9 billion Panadol tablets and 131 million tubes of Poligrip for global supply to over 70 markets.
We are incredibly excited about what the future holds for Haleon in Ireland and globally as we have set out ambitious growth targets which we are very confident of delivering thanks to the incredibly talented and committed team we have in Ireland.”
Haleon (pronounced “Hay-Lee-On”) was unveiled as the name of the business in February 2022 and is inspired by the merging of the words ‘Hale’, which is an old English word meaning ‘in good health’ and Leon, which is associated with the word ‘strength’.
The company’s signature “For Health. With Humanity” brings to life the essence and purpose of Haleon and was developed by its own colleagues. The signature will appear with our logo when space allows as it underscores the purpose of Haleon.
ENDS
